跳至主要内容
临床试验/NL-OMON45376
NL-OMON45376已完成2 期

Arterial wall inflammation measured with 18F-FDG PET/CT in patients with statin intolerance before and after treatment with a PCSK-9 inhibitor - VISTA

Vasculaire geneeskunde, Academisch Medisch Centrum0 个研究点目标入组 53 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
53

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Patients aged 50 years or older. With Statin-associated Muscle symptoms (SAMS) and Increased cardiovascular risk with high LDL-cholesterol.

排除标准

  • - Malignant diseases or any clinically significant medical condition that could interfere with the conduct of the study in the opinion of the investigator.
  • - Chronic or recent (<1 month) infections and/ or clinical signs of acute infection and/or CRP >10
  • - Auto-immune diseases
  • - Recent or chronic immunosuppresant / antibiotic usage
  • - Diabetes (type 1/ type 2)
  • - Standard contra-indications to 18F-FDG PET/CT based on psysicians experience and current practice.

研究者

发起方
Vasculaire geneeskunde, Academisch Medisch Centrum

相似试验

Arterial wall inflammation measured with 18F-FDG... | 临床试验